solagran announcement out, page-24

Bill thanks for coming back. I dont understand this "come back in december" talk thats getting around but Bills entitled to his opinion and personally I stirred him up to get him back.

So, yes SLA cannot patent vitamin E. However they can patent its use for much more powerful applications on physiological processes in conjunction with other compounds correct? A complicated task but one that will be achieved. Patent the extraction method, patent the product combination and hence patent the overall drug. Meaning no other company can copyright and manufacture the same product and apply it to the same target symptoms.

I cant remember but was your main concrern Bill - was it that the products dont work or the patents wont be pulled off?

Either way, SLA will be making some exciting revenues in the years to come solely in the Russian market so its more than just a compelling investment.